135 related articles for article (PubMed ID: 10851575)
1. Endocrine cancer risks for women during the perimenopause and beyond.
Leslie KK; Kumar NS
Semin Reprod Endocrinol; 1999; 17(4):359-70. PubMed ID: 10851575
[TBL] [Abstract][Full Text] [Related]
2. Sex steroids and breast cancer prevention.
Spicer DV; Pike MC
J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
[TBL] [Abstract][Full Text] [Related]
3. The prevention of breast cancer through reduced ovarian steroid exposure.
Spicer DV; Pike MC
Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
[TBL] [Abstract][Full Text] [Related]
4. Cancer risk in close relatives of women with early-onset breast cancer--a population-based incidence study.
Olsen JH; Seersholm N; Boice JD; Krüger Kjaer S; Fraumeni JF
Br J Cancer; 1999 Feb; 79(3-4):673-9. PubMed ID: 10027348
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
6. Risks of breast, endometrial, and ovarian cancers after twin births.
Ji J; Försti A; Sundquist J; Hemminki K
Endocr Relat Cancer; 2007 Sep; 14(3):703-11. PubMed ID: 17914100
[TBL] [Abstract][Full Text] [Related]
7. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
8. Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer?
Schoen RE; Weissfeld JL; Kuller LH
Am J Gastroenterol; 1994 Jun; 89(6):835-42. PubMed ID: 8198091
[TBL] [Abstract][Full Text] [Related]
9. Use of HRT and the subsequent risk of cancer.
Beral V; Banks E; Reeves G; Appleby P
J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
[TBL] [Abstract][Full Text] [Related]
10. Infertility as a cancer risk factor - a review.
Cetin I; Cozzi V; Antonazzo P
Placenta; 2008 Oct; 29 Suppl B():169-77. PubMed ID: 18790330
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and progesterone in breast and gynecologic cancers. Etiology, therapeutic role, and hormone replacement.
Nason FG; Nelson BE
Obstet Gynecol Clin North Am; 1994 Jun; 21(2):245-70. PubMed ID: 7936544
[TBL] [Abstract][Full Text] [Related]
12. [Cancer risk in women: a possible connection with geographic and certain economic and social factors].
Borisenkov MF; Anisimov VN
Vopr Onkol; 2011; 57(3):343-54. PubMed ID: 21882606
[TBL] [Abstract][Full Text] [Related]
13. Links between hormone replacement therapy and neoplasia.
Hulka BS
Fertil Steril; 1994 Dec; 62(6 Suppl 2):168S-175S. PubMed ID: 7958013
[TBL] [Abstract][Full Text] [Related]
14. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.
Salazar-Martinez E; Lazcano-Ponce EC; Gonzalez Lira-Lira G; Escudero-De los Rios P; Salmeron-Castro J; Hernandez-Avila M
Cancer Res; 1999 Aug; 59(15):3658-62. PubMed ID: 10446978
[TBL] [Abstract][Full Text] [Related]
15. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review.
Kaaks R; Lukanova A; Kurzer MS
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1531-43. PubMed ID: 12496040
[TBL] [Abstract][Full Text] [Related]
16. The risk of breast, endometrial and ovarian cancer in users of hormonal preparations.
Bernstein L
Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):288-96. PubMed ID: 16611204
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer risk factors and second primary malignancies among women with breast cancer.
Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
[TBL] [Abstract][Full Text] [Related]
18. Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings.
Persson I
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):357-64. PubMed ID: 11162945
[TBL] [Abstract][Full Text] [Related]
19. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
20. [Carcinogenesis theory based on estrogen deficiency].
Suba Z
Orv Hetil; 2009 Jun; 150(25):1155-66. PubMed ID: 19497837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
